Home HOME Neoplasma 2024 Neoplasma Vol.71, No.5, p.509, 2024

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.71, No.5, p.509, 2024

Title: Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer
Author: Xixi Ying, Zheng Shi, Rongjun Shao, Guangxian You, Zhengbo Song

Abstract:

Keywords:
Published online: 18-Nov-2024
Year: 2024, Volume: 71, Issue: 5 Page From: 509, Page To: 509
doi:10.4149/neo_2024_231104N572COR


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.